Clinical Research | Novartis

Story
May 31, 2024
A legacy of blood cancer innovation
Media Release
Dec 11, 2023
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Story
Dec 21, 2022
Compassionate use: Providing access to much needed treatments
Story
Jun 23, 2022
Renewing our commitment to neglected tropical disease and malaria elimination
Story
Dec 06, 2021
When it comes to cancer, there’s power in a good partner
Media Release
Dec 16, 2019
Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
Media Release
Apr 22, 2020
Novartis announces data showing Jakavi® (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease
Story
Jun 04, 2019
Toward improving the health and longevity of transplanted organs
Story
Oct 01, 2018
Researchers boost understanding of T-cell therapy in blood cancer
Story
Apr 20, 2020
Going the extra mile to keep clinical trials on track during the COVID-19 pandemic
Story
Sep 08, 2015
Putting patients first
Story
Jul 09, 2020
Cancer didn’t stop for COVID-19